Literature DB >> 24417192

Instrumental activities of daily living are impaired in Parkinson's disease patients with mild cognitive impairment.

Eva Pirogovsky1, Dawn M Schiehser1, Kristalyn M Obtera1, Mathes M Burke1, Stephanie L Lessig1, David D Song1, Irene Litvan1, J Vincent Filoteo1.   

Abstract

OBJECTIVE: Although it is well known that Parkinson's disease (PD) with dementia results in functional decline, little is known about the impact of mild cognitive impairment in PD (PD-MCI) on day-to-day functioning.
METHOD: Forty-one individuals with PD-MCI, 56 PD patients with normal cognition (PD-NC), and 47 healthy older adults were administered two performance-based measures of instrumental activities of daily living (IADLs) that evaluated medication and financial management. Informants of the PD patients were also administered an IADL questionnaire.
RESULTS: There were no significant differences between PD-NC and healthy older adults on the performance-based measures of medication and financial management. However, PD-MCI patients demonstrated significantly lower scores on the performance-based measures of medication and financial management compared with healthy older adults. PD-MCI patients were also impaired compared with PD-NC patients on performance-based medication management, but no difference between these groups was observed for ability to manage finances. Performance-based financial and medication management did not correlate with scores on neuropsychological measures in PD-MCI patients. PD-MCI and PD-NC patients showed comparable scores on the informant-based IADL questionnaire.
CONCLUSIONS: Performance-based measures of IADLs, particularly medication management ability, are sensitive to subtle functional declines in PD-MCI. Although impairment in performance-based measures is associated with cognitive status in PD, IADLs may be a separate domain of functioning from cognitive functioning in PD-MCI as these measures did not correlate with performance on the neuropsychological measures. Overall, performance-based assessment of IADLs may add to the clinical evaluation of PD-MCI. PsycINFO Database Record (c) 2014 APA, all rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24417192     DOI: 10.1037/neu0000045

Source DB:  PubMed          Journal:  Neuropsychology        ISSN: 0894-4105            Impact factor:   3.295


  29 in total

1.  Medication Management Capacity and Its Neurocognitive Correlates in Huntington's Disease.

Authors:  Catherine A Sumida; Emily J Van Etten; Francesca V Lopez; David P Sheppard; Eva Pirogovsky-Turk; Jody Corey-Bloom; J Vincent Filoteo; Steven P Woods; Paul E Gilbert; Maureen Schmitter-Edgecombe
Journal:  Arch Clin Neuropsychol       Date:  2019-10-24       Impact factor: 2.813

2.  Cognition in non-demented Parkinson's disease vs essential tremor: A population-based study.

Authors:  Á Sánchez-Ferro; J Benito-León; E D Louis; I Contador; J Hernández-Gallego; V Puertas-Martín; F Bermejo-Pareja
Journal:  Acta Neurol Scand       Date:  2017-03-05       Impact factor: 3.209

3.  Subjective Cognitive Complaint in Parkinson's Disease Patients With Normal Cognition: Canary in the Coal Mine?

Authors:  Rachael Purri; Laura Brennan; Jacqueline Rick; Sharon X Xie; Benjamin L Deck; Lana M Chahine; Nabila Dahodwala; Alice Chen-Plotkin; John E Duda; James F Morley; Rizwan S Akhtar; John Q Trojanowski; Andrew Siderowf; Daniel Weintraub
Journal:  Mov Disord       Date:  2020-06-10       Impact factor: 10.338

4.  Determining a Short Form Montreal Cognitive Assessment (s-MoCA) Czech Version: Validity in Mild Cognitive Impairment Parkinson's Disease and Cross-Cultural Comparison.

Authors:  Ondrej Bezdicek; Markéta Červenková; Tyler M Moore; Hana Stepankova Georgi; Zdenek Sulc; David A Wolk; Daniel A Weintraub; Paul J Moberg; Robert Jech; Miloslav Kopecek; David R Roalf
Journal:  Assessment       Date:  2018-06-21

5.  The Penn Parkinson's Daily Activities Questionnaire-15: Psychometric properties of a brief assessment of cognitive instrumental activities of daily living in Parkinson's disease.

Authors:  Laura Brennan; Andrew Siderowf; Jonathan D Rubright; Jacqueline Rick; Nabila Dahodwala; John E Duda; Howard Hurtig; Matthew Stern; Sharon X Xie; Lior Rennert; Jason Karlawish; Judy A Shea; John Q Trojanowski; Daniel Weintraub
Journal:  Parkinsonism Relat Disord       Date:  2016-02-21       Impact factor: 4.891

6.  Associations between a patient-reported outcome (PRO) measure of sarcopenia and falls, functional status, and physical performance in older patients with cancer.

Authors:  Jennifer S Gewandter; William Dale; Allison Magnuson; Chintan Pandya; Charles E Heckler; Tatyana Lemelman; Breton Roussel; Rafa Ifthikhar; James Dolan; Katia Noyes; Supriya G Mohile
Journal:  J Geriatr Oncol       Date:  2015-09-11       Impact factor: 3.599

7.  Development and initial testing of the Penn Parkinson's Daily Activities Questionnaire.

Authors:  Laura Brennan; Andrew Siderowf; Jonathan D Rubright; Jacqueline Rick; Nabila Dahodwala; John E Duda; Howard Hurtig; Matthew Stern; Sharon X Xie; Lior Rennert; Jason Karlawish; Judy A Shea; John Q Trojanowski; Daniel Weintraub
Journal:  Mov Disord       Date:  2015-08-07       Impact factor: 10.338

8.  Validation of a performance-based assessment of cognitive functional ability in Parkinson's disease.

Authors:  Samantha K Holden; Luis D Medina; Brian Hoyt; Stefan H Sillau; Brian D Berman; Jennifer G Goldman; Daniel Weintraub; Benzi M Kluger
Journal:  Mov Disord       Date:  2018-10-10       Impact factor: 10.338

9.  REM Sleep Behavior Disorder in Parkinson's Disease: Effects on Cognitive, Psychiatric, and Functional outcomes.

Authors:  Zanjbeel Mahmood; Ryan Van Patten; Marina Z Nakhla; Elizabeth W Twamley; J Vincent Filoteo; Dawn M Schiehser
Journal:  J Int Neuropsychol Soc       Date:  2020-05-07       Impact factor: 2.892

10.  Cognitive Functional Abilities in Parkinson's Disease: Agreement Between Patients and Informants.

Authors:  Benjamin L Deck; Sharon X Xie; Gyujae Choi; Jacqueline Rick; Andrew Siderowf; Samuel Rudovsky; Alice Chen-Plotkin; John E Duda; James F Morley; Nabila Dahodwala; John Q Trojanowski; Daniel Weintraub
Journal:  Mov Disord Clin Pract       Date:  2019-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.